Ensuring Access And Approval For Innovative Therapies In Scleroderma

Clinical research and development programs for innovative therapies in scleroderma must accommodate the diverse data needs of multiple stakeholders.

Related Keywords

Andrew Kuhlman ,Michaelf Murphy ,Melissa Vadnais ,Clinical Research Methodology ,Chief Medical And Scientific Officer ,